CanSino's Covid Vaccine Gets WHO Nod. But Is It Too Little, Too Late?

Key Takeaways:

• CanSino’s Covid-19 vaccine Convidecia will be admitted to the global Covax program following its approval by the WHO
• The approval could have limited benefits for the company as the pandemic fades and other products are widely available